Clinical Trial Update: A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study evaluating SHR-1819 given subcutaneously in healthy subjects, comparing different injection devices to assess pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SHR-1819

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Atopic Dermatitis | Phase 1 | Status: NOT_YET_RECRUITING